| |
| |
You're Invited to our Upcoming Webinar |
|
|
Integrated Clinical Development and Supply: Breaking Down the Early-Development
Journey of a Small Molecule |
|
|
| |
In the era of seamless drug development, reducing time to the clinic and getting rapid regulatory approval has become the goal of nearly every early drug development sponsor. Handling drug development, manufacturing, and clinical supply efficiently can help sponsors save costs and provide maximum benefit for patients. In order to improve the efficiency of the drug development continuum, integrated solutions have become an effective option for sponsor companies to streamline the transition from early development to the clinic, in addition to providing timely clinical supplies to help keep study timelines and budgets on track. Learn more about: The definition of integrated solutions in the pharmaceutical industry The benefits and challenges of the integrated approaches Insights on whether integrated solutions can be the key to achieving today’s more aggressive development milestones. Along with a discussion, examples of real-life tactical and operational decisions involved in the integrated approach to drug development will be presented. |
|
|
| |
| |
Stephen Tindal
Director, Science and Technology
Catalent |
|
|
Mark A. Krook, Ph.D.
NGT BioPharma Consultants |
|
|
| |
Arsalan Arif
Founder & Publisher
ENDPOINTS NEWS |
|
|
| |
Every molecule has a challenge. We have a solution.
|
|
|
| |
or call +1 877 891 9609 to speak with one of our experts today!
|
|
|
